Efficacy and safety of a novel antiviral herbal preparation in ICU-admitted patients with COVID-19: A phase III double-blinded controlled trial

• Príomhchruthaitheoirí: Hossein Faramarzi (Údar), Ahmad Hosseinpour (Údar), Amirhossein Sahebkar (Údar), Vahid Khaloo (Údar), Parisa Chamanpara (Údar), Mohammad Reza Heydari (Údar), Sajad Najafi (Údar), Fatemeh Fotoohi Khankahdany (Údar), Ahmad Movahedpour (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Mashhad University of Medical Sciences, 2024-03-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Objective: Despite an increasing number of studies, there is as yet no definite treatment developed for the coronavirus disease 2019 (COVID-19). In this clinical trial, we examined the efficacy of a novel herbal antiviral preparation in critically ill COVID-19 patients.Materials and Methods: A total...